Tuesday, March 21, 2017

Angiotech Pharmaceuticals Completes Sale to Investor Syndicate Led by Vivo Capital and ZQ Capital

PALO ALTO, Calif. and VANCOUVER, British Columbia, March 21, 2017 /PRNewswire/ -- Angiotech Pharmaceuticals, a leading medical device company focused on high value medical consumables in the wound closure and ophthalmology sectors, today announced the completion of its sale to a group of...

March 21, 2017 at 03:53PM